Revolve Biotechnologies has developed a protein & nucleic acid evolution platform for rapidly discovering optimal lead candidates from libraries of billions of variants. We are applying the platform towards creating products and services in three focus areas: high-affinity antibodies for diagnostic and therapeutic applications, oncolytic RNA cancer therapeutics, and infrared fluorescent proteins for live deep-tissue imaging. We offer services for construction
of custom DNA variant libraries and high-affinity antibodies with
industry-leading quality and turn-around time.